SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-18-005952
Filing Date
2018-05-11
Accepted
2018-05-11 16:02:17
Documents
45
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0318_citiuspharma.htm 10-Q 245806
2 CERTIFICATION f10q0318ex31-1_citiuspharma.htm EX-31.1 10025
3 CERTIFICATION f10q0318ex31-2_citiuspharma.htm EX-31.2 10086
4 CERTIFICATION f10q0318ex32-1_citiuspharma.htm EX-32.1 4754
  Complete submission text file 0001213900-18-005952.txt   2395622

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ctxr-20180331.xsd EX-101.SCH 36994
6 XBRL INSTANCE FILE ctxr-20180331.xml EX-101.INS 350934
7 XBRL CALCULATION FILE ctxr-20180331_cal.xml EX-101.CAL 31244
8 XBRL LABEL FILE ctxr-20180331_lab.xml EX-101.LAB 297152
9 XBRL DEFINITION FILE ctxr-20180331_def.xml EX-101.DEF 113086
10 XBRL PRESENTATION FILE ctxr-20180331_pre.xml EX-101.PRE 205507
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38174 | Film No.: 18826813
SIC: 2834 Pharmaceutical Preparations